Company: KROS
Filing Date: 2025-04-23
Form Type: DEF 14A
Source: 0001104659-25-037982
Chunk: 87

Company: Keros Therapeutics, Inc.
Filing Date: 2025-04-23
Form: DEF 14A
Chunk 87
---
ating and Corporate Governance Committee Chair  | ​ | ​ | ​                       | ​ | 10,000 | ​ | ​ |
| Additional retainer for Nominating and Corporate Governance Committee member | ​ | ​ | ​                       | ​ |  5,000 | ​ | ​ |

Equity Compensation In addition to cash compensation, each non-employee director will be eligible to receive options. Any options granted under the non-employee director compensation policy will have a term of ten years from the date of grant, subject to earlier termination in connection with a termination of service. Vesting schedules for equity awards will be subject to the non-employee director’s continuous service on each applicable vesting date, provided that each option will vest in full upon a change in control of the Company. Upon the termination of service of the non-employee director for any reason other than death, disability or cause, his or her options granted under the non-employee director compensation policy shall remain exercisable for 12 months following his or her date of termination. Initial Award Each new non-employee director elected or appointed to our Board will be granted an initial, one-time option to purchase 20,000 shares of our common stock, which will vest in equal quarterly installments such that the option is fully vested on the third anniversary of the grant date. Annual Awards On the date of each annual meeting of stockholders of our Company, each non-employee director that continues to serve will be granted an option to purchase 10,000 shares of our common stock, each of which will vest in equal quarterly installments over the 12 months following the grant date, provided that such option will in any case be fully vested on the date of our next annual stockholder meeting.

61

TABLE OF CONTENTS

EQUITY COMPENSATION PLAN INFORMATION The following table summarizes our equity compensation plan information as of December 31, 2024. Information is included for equity compensation plans approved by our stockholders. We do not have any equity compensation plans not approved by our stockholders:

| Plan Category                                              
 Equity compensation plans approved by security holders:    | ​ 
 ​ | ​ 
 ​ | (a) Number ofSecurities to beIssued UponExercise ofOutstandingOptions, WarrantsAnd Rights 
 ​                                                                                         | ​ |         ​ | ​ | ​ 
 ​ | ​ 
 ​ | (b) Weighted-AverageExercise Price ofOutstanding Options,Warrants andRights 
 ​                                                                           | ​ |     ​ | ​ | ​ 
 ​ | ​